Fu, Q., Shen, Q., Tong, J., Huang, L., Cheng, Y., & Zhong, W. (2021). Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Fu, Qiang, Qian Shen, Jin Tong, Liu Huang, Yi Cheng, et Wei Zhong. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Fu, Qiang, et al. Anti-Tumor Necrosis Factor Receptor 2 Antibody Combined With Anti-PD-L1 Therapy Exerts Robust Antitumor Effects in Breast Cancer. Frontiers Media S.A, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.